Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
290.50    0.40 (0.14%)
Bid:
290.50
Ask:
290.70
Spread: 0.20 (0.069%)
Market Cap: £15.89b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Directorate Change

17 Jun 2022 07:00

RNS Number : 2184P
Legal & General Group Plc
17 June 2022
 

 

Legal & General Group Plc Board announces the appointment of Carolyn Johnson as a non-executive director of Legal & General Group Plc

 

 

17 June 2022

 

The Board of Legal & General Group Plc (the "Company") is pleased to announce the appointment of Carolyn Johnson as an independent non-executive director of the Company with immediate effect. Carolyn will join the Group Audit, Group Risk and Group Nominations and Corporate Governance Committees upon appointment.

 

Carolyn has extensive knowledge of the insurance and financial services industries following a 30-year executive career in the United States. In particular, she has deep experience in the life insurance market, having held senior roles at AIG, Voya Financial and Protective Life Corporation.

 

Carolyn Johnson was a director of Majesco, Inc until 2020. There is no other additional information required to be disclosed in relation to Carolyn Johnson pursuant to LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

Sir John Kingman, Group Chairman, said:

 

"I am delighted to welcome Carolyn to the Group Board. Carolyn brings with her a wealth of experience in insurance and in financial services more generally. Her appointment will strengthen the Board's engagement with our successful and growing US businesses in life insurance, asset management and pension risk transfer. I very much look forward to working with her."

 

In addition, the Board of the Company is pleased to annouce that Laura Wade-Gery will become chair of the Group Technology Committee with effect from 1 September 2022.

 

Laura Wade-Gery joined the Board on 3 January 2022 as a non-executive director and is a member of the Group Technology Committee and Group Nominations and Corporate Governance Committee.

 

Notes to Editors

Legal & General Group Plc

 

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with over £1.4 trillion in total assets under management of which a third is international. L&G also provides powerful asset origination capabilities. Together, these underpin our leading retirement and protection solutions: we are a leading international player in pension risk transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. As at 16 June 2022, Legal & General has a market capitalisation of £14.6 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGMVGVDGZZZ
Date   Source Headline
22nd Jul 202010:27 amRNSHolding(s) in Company
15th Jul 20204:13 pmRNSHolding(s) in Company
8th Jul 20207:00 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20205:00 pmRNSDirector/PDMR Shareholding
2nd Jul 20205:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20205:30 pmRNSDirector/PDMR Shareholding
1st Jul 20205:00 pmRNSDirector/PDMR Shareholding
1st Jul 20205:00 pmRNSBlock listing Interim Review
1st Jul 20205:00 pmRNSTotal Voting Rights
1st Jul 20205:00 pmRNSDirector/PDMR Shareholding
24th Jun 20205:02 pmRNSDirector/PDMR Shareholding
24th Jun 20207:39 amRNSHolding(s) in Company
22nd Jun 20204:06 pmRNSPublication of Final Terms
22nd Jun 20203:30 pmRNSHolding(s) in Company
18th Jun 20209:30 amRNSDirector Declaration
16th Jun 202010:06 amRNSL&G plans to capitalise on favourable market condi
11th Jun 20201:52 pmRNSHolding(s) in Company
10th Jun 20205:30 pmRNSDirector/PDMR Shareholding
9th Jun 20205:00 pmRNSDirector/PDMR Shareholding
5th Jun 20205:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20205:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20205:00 pmRNSDirector/PDMR Shareholding
1st Jun 20205:00 pmRNSTotal Voting Rights
1st Jun 20205:00 pmRNSDirector/PDMR Shareholding
1st Jun 20205:00 pmRNSDirector/PDMR Shareholding
29th May 20204:21 pmRNSHolding(s) in Company
21st May 202012:06 pmRNSResult of AGM
20th May 20205:21 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
15th May 20204:09 pmRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
4th May 20205:00 pmRNSDirector/PDMR Shareholding
1st May 20205:00 pmRNSDirector/PDMR Shareholding
1st May 20205:00 pmRNSDirector/PDMR Shareholding
1st May 20205:00 pmRNSTotal Voting Rights
1st May 20202:30 pmRNSHolding(s) in Company
1st May 20208:30 amRNSPublication of Final Terms
29th Apr 20205:37 pmRNSHolding(s) in Company
28th Apr 20206:02 pmRNSNotification of Major Holdings
28th Apr 20205:43 pmRNSHolding(s) in Company
27th Apr 20207:00 amRNSHolding(s) in Company
24th Apr 202010:38 amRNSDisclosure of rights attached to equity shares
24th Apr 202010:28 amRNSHolding(s) in Company
24th Apr 20208:55 amRNSStrategy/Company/Ops Update
24th Apr 20208:00 amRNSHolding(s) in Company
20th Apr 20205:30 pmRNSDirector/PDMR Shareholding
20th Apr 20209:09 amRNSNotice of AGM
14th Apr 20205:00 pmRNSDirector/PDMR Shareholding
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.